A pharmacy led program to review anti-psychotic prescribing for people with dementia

BMC Psychiatry

Volumn 12, Issue , 2012, Pages

  Child, Anne ^a   Clarke, Amy ^b   Fox, Chris ^c   Maidment, Ian ^d  

^a De Gelsey House   (United Kingdom)

^b NHS Medway   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d ASTON UNIVERSITY   (United Kingdom)

Author keywords

Anti psychotics; Dementia Registers; Medication Review; National Dementia Strategy

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; DEMENTIA; FISHER EXACT TEST; HEALTH SERVICE; HOME CARE; HUMAN; INFORMATION PROCESSING; LEARNING; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MEDICAL INFORMATION; MENTAL HEALTH; PHARMACY; PRIMARY MEDICAL CARE; REGISTER; UNITED KINGDOM; INAPPROPRIATE PRESCRIBING; INFORMATION SYSTEM; MEDICATION THERAPY MANAGEMENT; MENTAL HEALTH SERVICE; PHARMACY TECHNICIAN; PRESCRIPTION; PUBLIC HEALTH; RESIDENTIAL HOME; SECONDARY HEALTH CARE;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DATABASES, FACTUAL; DEMENTIA; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; RESIDENTIAL FACILITIES;

EID: 84866534430     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-12-155     Document Type: Article

References (37)

1. Alzheimer's Disease International World Alzheimer Report 2009, Available on www.alz.co.uk/research/files/WorldAlzheimerReport.pdf (accessed 21st January 2012), Alzheimer's Disease International.
2. Department of Health Living well with dementia: a national dementia strategy. London, Stationary Office 2009, Available on http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_094051.pdf (accessed 31st January 2012), Department of Health.
3. Health and Social Care Information Centre (HSCIC) National Dementia and Anti-psychotic Prescribing Audit 2012, Available on www.ic.nhs.uk/dementiaaudit (accessed 31st July 2012), Health and Social Care Information Centre (HSCIC).
4. Savva GM, Zaccai J, Matthews FE, Davidson JE, McKeith I, Brayne C. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry 2009, 2009:212-219.
5. Ballard C, Waite J. Atypical anti-psychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Cochrane Collaboration John Wiley & Sons, Ltd, 10.1002/14651858.CD003476.pub2, 15207448.
6. Parnetti L, Amici S, Lanari A, Gallai V. Pharmacological treatment of non-cognitive disturbances in dementia disorders. Mech Ageing Dev 2001, 122:2063-2069. 10.1016/S0047-6374(01)00316-5, 11589923.
7. Torti FM, Gwyther LP, Reed SD, Friedman JY, Schulman KA. A multinational review of recent trends and reports in dementia caregiver burden. Alzh Dis Ass Disord 2004, 18:99-109.
8. Gallicchio L, Siddiqi N, Langenberg P, Baumgarten M. Gender differences in burden and depression among informal caregivers of demented elders in the community. Int J Geriatr Psychiatry 2002, 17:154-163. 10.1002/gps.538, 11813279.
9. Gaugler JE, Kane RL, Kane RA, Newcomer R. Unmet care needs and key outcomes in dementia. JAGS 2005, 53:2098-2105.
10. Etters L, Goodall D, Harrison BE. Caregiver burden among dementia patient caregivers: A review of the literature. J Am Acad Nurse Pract 2008, 20:423-428. 10.1111/j.1745-7599.2008.00342.x, 18786017.
11. Souetre E, Thwaites RMA, Yeardley HL. Economic impact of Alzheimer's disease in the United Kingdom: Cost of care and disease severity for non-institutionalized patients with Alzheimer's disease. Br J Psychiatry 1999, 174:51-55. 10.1192/bjp.174.1.51, 10211151.
12. Gaugler JE, Yu F, Krichbaum K, Wyman JF. Predictors of nursing home admission for person with dementia. Med Care 2009, 47:191-198. 10.1097/MLR.0b013e31818457ce, 19169120.
13. Department of Health National Service Framework for Older People. London, Stationary Office 2001, Available on http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4071283.pdf (accessed 14th April), Department of Health.
14. Department of Health The use of anti-psychotic medication for people with dementia: Time for action Living well with dementia: A National Dementia Strategy 2009, London: Stationary Office, Available on www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_108303(accessed 14th April), Department of Health.
15. Department of Health Quality outcomes for people with dementia: building on the work of the National Dementia Strategy 2010, London: Stationary Office, Available on http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_119827 (accessed 14th April), Department of Health.
16. Maidment ID, Fox C, Boustani M, Katona C. Medication management - the missing link in dementia interventions. Int J Geriatr Psychiatry 2011,
17. Medway Council Population 2010, Available onhttp://www.medway.gov.uk/pdf/Population%20July%202011.pdf (accessed 31st March 2012), Medway Council.
18. Medway Council Index of Deprivation 2010, Available on http://www.medway.gov.uk/pdf/Indices%20of%20Deprivation%202010.pdf (accessed 31st March 2012), Medway Council.
19. Health and Social Care Information Centre (HSCIC) The Quality and Outcomes Framework 2010/11, Available on http://www.ic.nhs.uk/qof (accessed 31st July 2012), Health and Social Care Information Centre (HSCIC).
20. National Audit Office Improving Dementia Services in England - an Interim Report: GP Survey Results 2010, Available on http://www.nao.org.uk/default.aspx (accessed 31st July 2012), National Audit Office.
21. BMA / RPS (British Medical Association / Royal Pharmaceutical Society) British National Formulary 62 2011, Basingstoke: Pharmaceutical Press, BMA / RPS (British Medical Association / Royal Pharmaceutical Society).
22. Alzheimer's Society Optimising treatment and care for behavioural and psychological symptoms of dementia: A best practice guide 2011, London: Alzheimer's Society, Available on http://www.alzheimers.org.uk/site/scripts/download_info.php?fileID=1163 (accessed 14th April 2012), Alzheimer's Society.
23. NHS Kent Treatment of behaviour in dementia that challenges 2011, Available on http://www.easternandcoastalkent.nhs.uk/home/independent-contractors/medicines-management/drug-formulary-and-prescribing-policies/central-nervous-system/ (accessed 31st July 2012), NHS Kent.
24. Medicines and Health Regulatory Authority (MHRA) Anti-psychotics: use in elderly people with dementia. Drug Safety Update 2009, 2, 8 Available on http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON088116(accessed 14th February 2012), Medicines and Health Regulatory Authority (MHRA).
25. National Prescribing Centre Medication Review reference - Guide to medication review 2008 2008, NPC Plus, http://www.npc.nhs.uk/review_medicines/intro/resources/agtmr_web1.pdf (accessed 24th September 2012), National Prescribing Centre.
26. GraphPad Software Inc Analyze a 2 x 2 contingency table 2005, Available on http://www.graphpad.com/quickcalcs/contingency2.cfm (accessed 23rd March 2012), GraphPad Software Inc.
27. Connolly A, lliffe S, Gaehl E, Campbell S, Drake A, Morris J, Purandare N. Quality of care provided to people with dementia: utilisation and quality of the annual dementia review in general practice. Br J Gen Pract 2012, 62:e91-e98. 10.3399/bjgp12X625148, 22520775.
28. Goodwin N, Curry N, Naylor C, Ross S, Duldig W. Managing people with long-term conditions - an inquiry into the quality of General Practice in England 2010, London: The King's Fund, Available on www.kingsfund.org.uk/document.rm?id=8757 (accessed 25th March 2012).
29. Alzheimer's Society PCT dementia prevalence and diagnosis rates Available on http://www.alzheimers.org.uk/site/scripts/directory_home.php?directoryID=13 (accessed 24th March 2012), Alzheimer's Society.
30. Cameron A. QOF Dementia register size vs. Expected Dementia prevalence. Letter - NHS Dumfries and Galloway 2010, Available on http://www.qihub.scot.nhs.uk/media/216077/appendix2.pdf (accessed 11th April 2012).
31. Connelly PJ, Law E, Angus S, Prentice N. Fifteen year comparison of anti-psychotic use in people with dementia within hospital and nursing home settings: sequential cross sectional study. Int J Geriatr Psychiatry 2010, 25:160-165. 10.1002/gps.2313, 19513989.
32. Bishara D, Taylor D, Howard RJ, Abdel-Tawab R. Expert opinion on the management of behavioural and psychological symptoms of dementia (BPSD) and investigation into prescribing practices in the UK. Int J Geriatr Psychiatry 2009, 24:944-954. 10.1002/gps.2200, 19156700.
33. Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA. CATIE-AD Study Group. Effectiveness of atypical anti-psychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006, 355:1525-1538. 10.1056/NEJMoa061240, 17035647.
34. Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Efficacy and Comparative Effectiveness of Atypical Anti-psychotic Medications for Off-Label Uses in Adults - A Systematic Review and Meta-analysis. JAMA 2011, 306:1359-1369. 10.1001/jama.2011.1360, 21954480.
35. Huybrechts KF, Gerhard T, Crystal S, Olfson M, Avorn J, Levin R, Lucas JA, Schneeweiss S. Differential risk of death in older residents in nursing homes prescribed specific anti-psychotic drugs: population based cohort study. BMJ 2012, 344:e977. 10.1136/bmj.e977, 3285717, 22362541.
36. Committee on Safety of Medicines Atypical Anti-psychotics and stroke 2004, Available on http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019488.pdf (accessed 14th February 2012), Committee on Safety of Medicines.
37. Maidment I, Fox C, Katona C. An evaluation of an outreach role for specialist mental health pharmacists. International Conference on Alzheimer's Disease 2011, Paris: International Meeting.